Becker's Healthcare January 16, 2025
Rylee Wilson

Optum Rx will pass 100% of the rebates it negotiates for drugs onto its consumers by the end of 2028, UnitedHealth Group CEO Andrew Witty told investors.

On the company’s fourth-quarter earnings call on Jan. 16, Mr. Witty told investors most of the pharmaceutical benefit manager’s clients choose plans where they receive the full amount of rebates. A few choose other models.

“We are committed to fully phasing out those arrangements so that 100% of rebates will go to customers by 2028 at the latest. We will continue to encourage all of our clients to fully pass these savings directly to patients at the point of sale, as we already do for all of the people we serve in...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Insurance, Payer, Pharma, Pharma / Biotech
Community Pharmacists as Experts on Complex Patient Encounters
On Heels of FDA Nod, BridgeBio’s Rival to Blockbuster Pfizer Drug Wins European Approval
Medicare’s Drug Price Negotiation And Innovation: What’s Off The Table Matters Too
Walgreens PE deal back on the table: 5 things to know
Pharma Pulse 2/21/25: RWE in Medical Research and Drug Development, Inhaled Antibody Therapy for RSV & more

Share This Article